NVP-AUY922:: A novel small molecule HSP90 inhibitor with potent in vivo antitumor efficacy

被引：0

作者：

Jensen, Michael Rugaard ^{[1
]}

Schoepfer, Joseph ^{[1
]}

Radimersky, Thomas ^{[1
]}

Massey, Andrew ^{[2
]}

Brueggen, Josef ^{[1
]}

Schweitzer, Alain ^{[3
]}

Pfaar, Ulrike ^{[3
]}

Ruetz, Stephan ^{[1
]}

Guy, Chantal ^{[4
]}

Buckler, Alan ^{[4
]}

Schnell, Christian ^{[1
]}

Cozens, Robert ^{[1
]}

Brough, Paul ^{[2
]}

Drysdale, Martin ^{[2
]}

Quadt, Cornelia ^{[3
]}

Garcia-Echeverria, Carlos ^{[1
]}

Chene, Patrick ^{[1
]}

机构：

[1] Novartis Inst BioMed Res, Basel, Switzerland

[2] Vernalis Ltd, Cambridge, England

[3] Novartis Pharma AG, Basel, Switzerland

[4] Novartis Inst BioMed Res, Cambridge, England

来源：

MOLECULAR CANCER THERAPEUTICS | 2007年 / 6卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3521S / 3521S

页数：1

共 50 条

[31] HSP90 inhibitor NVP-AUY922 induces cell apoptosis by disruption of the survivin in papillary thyroid carcinoma cells
Liu, Jinhao
Sun, Wei
Dong, Wenwu
Wang, Zhihong
Qin, Yuan
Zhang, Ting
Zhang, Hao
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 487 (02) : 313 - 319
[32] Heat-shock protein (Hsp) 70 inhibition enhances the effect of the Hsp90 inhibitor NVP-AUY922 on melanoma cells
Yeramian, A.
Vea, A.
Santacana, M.
Matias-Guiu, X.
Marti, R. M.
BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (03) : E48 - E48
[33] Heat-shock protein (Hsp)70 inhibition enhances the effect of the Hsp90 inhibitor NVP-AUY922 on melanoma cells
Yeramian, A.
Vea, A.
Santacana, M.
Matias-Guiu, X.
Marti, R. M.
BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 : 36 - 36
[34] 89Zr-Bevacizumab PET of Early Antiangiogenic Tumor Response to Treatment with HSP90 Inhibitor NVP-AUY922
Nagengast, Wouter B.
de Korte, Maarten A.
Munnink, Thijs H. Oude
Timmer-Bosscha, Hetty
den Dunnen, Wifred F.
Hollema, Harry
de Jong, Johan R.
Jensen, Michael R.
Quadt, Cornelia
Garcia-Echeverria, Carlos
van Dongen, Guus A. M. S.
Lub-de Hooge, Marjolijn N.
Schroder, Carolien P.
de Vries, Elisabeth G. E.
JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (05) : 761 - 767
[35] NVP-BEP800: an orally bioavailable small molecule Hsp90 inhibitor with potent in vivo antitumor activity
Jensen, Michael
Schoepfer, Joseph
Massey, Andrew
Brough, Paul
Brueggen, Josef
Schweitzer, Alain
Pfaar, Ulrike
Quadt, Corneiia
Drysdale, Martin
Chene, Patrick
Garcia-Echeverria, Carlos
CANCER RESEARCH, 2009, 69
[36] Evaluation of the Hsp90 inhibitor NVP-AUY922 in multicellular tumour spheroids with respect to effects on growth and PET tracer uptake
Monazzam, Azita
Razifar, Pasha
Ide, Susan
Jensen, Michael Rugaard
Josephsson, Raymond
Blomqvist, Carl
Langstroemg, Bengt
Bergstroem, Mats
NUCLEAR MEDICINE AND BIOLOGY, 2009, 36 (03) : 335 - 342
[37] Pharmakokinetic/phamacodynamic relationship of the HSP90 inhibitor NVP-AUY922 in human xenografts and patients in a clinical Phase I trial
Jensen, Michael
Ide, Susan
Brueggen, Josef
Schoepfer, Joseph
Wang, Xiaofeng
Quadt, Cornelia
Garcia-Echeverria, Carlos
CANCER RESEARCH, 2009, 69
[38] Radiosensitization of HSF-1 Knockdown Lung Cancer Cells by Low Concentrations of Hsp90 Inhibitor NVP-AUY922
Kuehnel, Annett
Schilling, Daniela
Combs, Stephanie E.
Haller, Bernhard
Schwab, Melissa
Multhoff, Gabriele
CELLS, 2019, 8 (10)
[39] The HSP90 Inhibitor NVP-AUY922 Radiosensitizes by Abrogation of Homologous Recombination Resulting in Mitotic Entry with Unresolved DNA Damage
Zaidi, Shane
McLaughlin, Martin
Bhide, Shreerang A.
Eccles, Suzanne A.
Workman, Paul
Nutting, Christopher M.
Huddart, Robert A.
Harrington, Kevin J.
PLOS ONE, 2012, 7 (04):
[40] Bioluminescence Imaging to Monitor the Effects of the Hsp90 Inhibitor NVP-AUY922 on NF-κB Pathway in Endometrial Cancer
Andree Yeramian
Virginia García
Laura Bergadà
Mónica Domingo
Maria Santacana
Joan Valls
Montserrat Martinez-Alonso
José-Antonio Carceller
Antonio Llombart Cussac
Xavier Dolcet
Xavier Matias-Guiu
Molecular Imaging and Biology, 2016, 18 : 545 - 556

← 1 2 3 4 5 →